FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5. [PDF]
Takeda K+5 more
europepmc +1 more source
BCR-ABL kinase domain mutations in CML patients, experience from a tertiary care center in North India. [PDF]
S A+6 more
europepmc +1 more source
Chronic myeloid leukemia with two rare fusion gene transcripts of atypical BCR::ABL: A case report and literature review. [PDF]
Li Y+6 more
europepmc +1 more source
Integrating amino acids into Bcr-Abl inhibitors: design, synthesis, biological evaluation, and in silico studies. [PDF]
Liu Y+9 more
europepmc +1 more source
Editor's Note to: Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1-BCR-ABL-JAK2 Complex. [PDF]
europepmc +1 more source
The molecular signature of BCR::ABLP210 and BCR::ABLT315I in a Drosophila melanogaster chronic myeloid leukemia model. [PDF]
Baassiri A+5 more
europepmc +1 more source
Hyperfunction of neutrophils in a patient with BCR/ABL negative chronic myeloid leukemia
Kiyoshi Watari+7 more
openalex +1 more source